The case for expanding worldwide access to point of care molecular drug susceptibility testing for isoniazid

Vanessa B. Vogensen, Richard M. Anthony, Huib A.M. Kerstjens, Simon Tiberi, Jurriaan E.M. de Steenwinkel, Onno W. Akkerman*

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)1047-1049
Number of pages3
JournalClinical Microbiology and Infection
Issue number8
Publication statusPublished - Aug 2022

Cite this